Even though the identified immune-reactive molecular subtype of HGSOC showed significantly longer OS, immunosuppressive networks in the ovarian tumor microenvironment (TME), such as regulatory T cells (Treg), indoleamine 2,3-dioxygenase (IDO), IL-10, programmed death-ligand (PD-L1), myeloid cells and vascular endothelial growth factor (VEGF), are associated with tumor progression and poor prognosis, thus impeding the efficacy of immunotherapy [11,12]. The gene discussed is VEGFA; the disease is ovarian neoplasm.